The mean change in body weight from baseline to week 104 was 15.2% in the semaglutide group ( n = 152) versus 2.6% with placebo ( n = 152), for an estimated treatment difference of 12.6 %-points (95% confidence interval, 15.3 to 9.8
Obesity treatment guidelines also recommend adjunct treatment with pharmacotherapies such as GLP-1 RAs when initial treatment through lifestyle interventions (nutrition, physical activity, and behavioral modifications) are unsuccessful [9,10,11,12]
#weightlosshelp #glp #semaglutide #tirzepatide #obesitymedicine | Sp Wellness
In the past few years, IV glutathione therapy has received a great deal of attention
Learn more in the press release here: #PRESS To view or add a comment, sign in Happy Mothers Day
10.1074/jbc.270.21.12471 J